Triple therapy study for H. pylori infection
Part of Infections clinical trials.
This study tests a triple therapy drug combination to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach problems. It may help people with certain stomach conditions who need to get rid of the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have tested positive for H. pylori (a stomach bacteria).
- You have a stomach condition like chronic gastritis, a peptic ulcer, or a family history of stomach cancer, among others.
- You have not already been treated for H. pylori in the past.
- You are not allergic to penicillin or macrolide antibiotics (like azithromycin).
- You are not pregnant or nursing, and you agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dual therapy (Keverprazan Hydrochloride plus amoxicillin) against a standard quadruple therapy guided by antibiotic sensitivity. It is for people whose H. pylori infection has not been cured by at least one prior treatment.
This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.
This study tests a three-medicine combination (bismuth, tetracycline, and rabeprazole) as a first treatment to get rid of an H. pylori infection, a common stomach bacteria that can cause ulcers and other problems. The aim is to see if this treatment works well and is safe, so it might help you clear the infection and improve your stomach health.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.
This study compares several different 2-week treatment plans to see which works best for wiping out H. pylori, a bacteria that can cause stomach ulcers and other digestive problems. If you have H. pylori, you may be able to join and receive one of the treatments.
Hear when a new Helicobacter Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.